Arsenic trioxide and the growth of human T-cell leukemia virus type I infected T-cell lines

Leukemia and Lymphoma

Volumn 37, Issue 5-6, 2000, Pages 649-655

  Ishitsuka, Kenji ^a,b   Hanada, Shuichi ^a   Uozumi, Kimiharu ^a   Utsunomiya, Atae ^a   Arima, Terukatsu ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b NONE   (Japan)

Author keywords

Adult T cell leukemia; Apoptosis; Arsenic trioxide; G1 phase accumulation; Growth inhibition

Indexed keywords

ARSENIC TRIOXIDE; CASPASE; CASPASE INHIBITOR; KETONE DERIVATIVE; PROTEIN BAK; PROTEIN BCL 2; PROTEIN P21; PROTEIN P27; PROTEIN P53; RETINOBLASTOMA PROTEIN; ANTINEOPLASTIC AGENT; BAK1 PROTEIN, HUMAN; BENZYLOXYCARBONYLVALYL ALANYL ASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYL-ALANYL-ASPARTYL FLUOROMETHYL KETONE; CDKN1A PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLINE; CYSTEINE PROTEINASE INHIBITOR; MEMBRANE PROTEIN; ORGANOARSENIC DERIVATIVE; OXIDE; PEPTIDE CHLOROMETHYL KETONE; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ACUTE MYELOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL GROWTH; EDEMA; FATIGUE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; MYALGIA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RASH; T CELL LEUKEMIA; VERTIGO; BIOSYNTHESIS; CELL CULTURE; CELL LINE; DRUG EFFECT; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; PROTO ONCOGENE; T CELL LYMPHOMA; T LYMPHOCYTE; TUMOR SUPPRESSOR GENE; VIROLOGY;

AMINO ACID CHLOROMETHYL KETONES; ANTINEOPLASTIC AGENTS; APOPTOSIS; ARSENICALS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; CELL CYCLE PROTEINS; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; CYSTEINE PROTEINASE INHIBITORS; DRUG SCREENING ASSAYS, ANTITUMOR; G1 PHASE; GENE EXPRESSION REGULATION, LEUKEMIC; GENES, BCL-2; GENES, P53; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; MEMBRANE PROTEINS; NEOPLASM PROTEINS; OXIDES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-BCL-2; RETINOBLASTOMA PROTEIN; T-LYMPHOCYTES; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0034049583     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009058521     Document Type: Article

References (47)

1. Shimoyama, M. & members of the Lymphoma Study Group (1984-1987). (1991) Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia/lymphoma. Br. J. Haematol., 79, 428-437.
2. Hanada, S., Utsunomiya, A., Suzuki, S., Uozumi, K., Makino, T. and Arima, T. (1997) Treatment for adult T-cell leukemia. Cancer Chemother. Pharmacol., 40, Suppl 47-50.
3. Kuwazuru, Y., Hanada, S., Furukawa, T., Yoshimura, A., Sumizawa, T., Utsunomiya, A., Ishibashi, K., Saito, T., Uozumi, K., Maruyama, M., Ishizawa, M., Arima, T. and Akiyama, S. (1990) Expression of P-glycoprotein in adult T-cell leukemia cells. Blood, 76, 2065-2071.
4. Lau, A., Nightingale, S., Taylor, G.P., Gant, T.W. and Cann, A.J. (1998) Enhanced MDR1 gene expression in human T-cell leukemia virus-1-infected patients offers new prospects for therapy. Blood, 91, 2467-2474.
5. Ikeda, K., Oka, M., Yamada, Y., Soda, H., Fukuda, M., Kinoshita, A., Tsukamoto, K., Noguchi, Y., Isomoto, H., Takeshima, F., Murase, K., Kamihira, S., Tomonaga, M. and Kohno, S. (1999) Adult T-cell leukemia cells over-express the multidrug-resistance-protein (MRP) and lung-resistance-protein (LRP) genes. Int. J. Cancer, 82, 599-604.
6. Takatsuki, K., Yamaguchi, K. and Hattori, T. (1990) Adult T-cell leukemia/lymphoma. In Retrovirus biology and human disease. edited by Gallo, R.C. and Wong-Staal, F. pp 147-159.
7. 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood, 89, 3354-60.
8. 3) in the treatment of acute promyelocytic leukemia: As203 induces NB4 cell apoptosis with downregulation of bcl-2 expression and modulation of PML-RARα/PML proteins. Blood, 88, 1052-1061.
9. Soignet, S.L., Maslak, P., Wang, Z.G., Jhanwar, S., Calleja, E., Dardashti, L.J., Corso, D., DeBlasio, A., Gabrilove, J., Scheinberg, D.A., Pandolfi, P.P. and Warrell, R.P. Jr. (1998), Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide. N. Engl. J. Med., 339, 1341-1348.
10. Zhang, W., Ohnishi, K., Shigeno, K., Fujisawa, S., Naito, K., Nakamura, S., Takeshita, K., Takeshita, A. and Ohno, R. (1998) The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms. Leukemia, 12, 1383-1391.
11. Dai, J., Weinberg, R.S., Waxman, S. and Jing, Y. (1999) Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood, 93, 268-277.
12. Zhu, X.H., Shen, Y.L., Jing, Y.K., Cai, X., Jia., P.M., Huang, Y., Tang, W., Shi, G.Y., Sun, Y.P. Dai, J., Wang, Z.Y., Chen, S.J., Zhang, T.D., Waxman, S., Chen, Z. and Chen, G.Q. (1999) Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations. J. Natl. Cancer. Inst., 91, 772-77K.
13. Konig, A., Wrazel, L., Warrell, R.P. Jr., Rivi, R., Pandolfi, P.P., Jakubowski, A. and Gabrilove, J.L. (1997) Comparative activity of melarsoprol and arsenic trioxide in chronic B-cell leukemia lines. Blood, 90, 562-70.
14. Rousselot, P., Labaume, S., Marolleau, J.P., Larghero, J., Noguera, M.H., Brouet, J.C. and Fermand, J.P. (1999) Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients. Cancer Res., 59, 1041-1048.
15. Miyoshi, I., Kubonishi, I., Sumida, M., Hiraki, S., Tsubota, T., Kimura, I., Miyamoto, K. and Sato, J. (1980) A novel T-cell line derived from adult T-cell leukemia. Gann, 71, 155-156.
16. Miyoshi, I., Kubonishi, I., Yoshimoto, S. and Shiraishi, Y. (1981) A T-cell line derived from normal human cord leukocytes by co-culturing with human leukemic T-cells. Gann, 72, 978-981.
17. Hanada, S., Tsubai, F. & Namba, Y. (1985) The characteristics of T-cell lines derived from peripheral blood of patients with adult T-cell leukemia-lymphoma. Recent Advances in RES Research, 25, 124.
18. Ishitsuka, K., Hanada, S., Suzuki, S., Utsunomiya, A., Chyuman, Y., Takeuchi, S., Takeshita, T., Shimotakahara, S., Uozumi, K., Makino, T. and Arima, T. (1998) Arsenic trioxide inhibits growth of human T-cell leukumia virus type I infected T-cell lines more effectively than retinoic acids. Br. J. Haematol., 103, 721-728.
19. Bazarbachi, A., EL-Sabban, M.E., Nasr, R., Quignon, F., Awaraji, C., Kersual, J., Dianoux, L., Zernati, Y., Haider, J.H., Hermine, O. and de, The, H. (1999) Arsenic trioxide and interferon-α synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotrophic virus type I-transformed cells. Blood, 93, 278-283.
20. 1 phase to HTLV-I infected T-cell lines with modulation of bak and Kip1/p27 expression. Blood, 92, Suppl 1, 245a.
21. Zamai, L., Falcieri, E., Zauli, G., Cataldi, A. and Vitale, M. (1993) Optimal detection of apoptosis by flow cytometry depends on cell morphology. Cytometry; 14, 891-897.
22. Gavrieli, Y., Sherman, Y. and Ben-Sasson, S.A. (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J, Cell, Biol., 119, 493-501.
23. Zhang, C., Ao, Z., Seth,A. and Schlossman, S.F. (1996) A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells. J Immunol. 157, 3980-3987.
24. Vermes, I., Haanen, C., Steffens-Nakken, H. and Reutelingsperger, C. J. (1995) A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods., 184, 39-51.
25. Hockenbery, D.M., Oltvai, Z.N., Yin, X.M., Milliman, C.L. and Korsmeyer, S.J. (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell, 75, 241-251.
26. Reed, J.C. (1994) Bcl-2 and the regulation of programmed cell death. J. Cell. Biol., 124, 1-6.
27. Boise, L.H., Gonzalez, G.M., Postema, C. E., Ding, L., Lindsten, T., Turka, L.A., Mao, X., Nunez, G. and Thompson, C.B. (1993) bcl-X, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74, 597-608.
28. Oltvai, Z.N., Milliman, C.L. and Korsmeyer, S.J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74, 609-619.
29. Farrow, S.N., White, J.H., Martinou, I., Raven, T., Pun, K.T., Grinham, C.J., Martinou, J.C. and Brown, R. (1995) Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K, Nature, 374, 731-733.
30. Chittenden, T., Harrington, E.A., O'Connor, R., Flemington, C., Lutz, R.J., Evan, G.I. and Guild, B.C. (1995) Induction of apoptosis by the Bcl-2 homologue Bak. Nature, 374, 733-736.
31. Cheng, E.H., Kirsch, D.G., Clem, R.J., Ravi, R., Kastan, M.B., Bedi, A., Ueno, K. and Hardwick, J.M. (1997) Conversion of Bcl-2 to a Bax-like death effector by caspases. Science, 278, 1966-1968.
32. Fujita, N. and Tsuruo, T. (1998) Involvement of Bcl-2 cleavage in the acceleration of VP-16-induced U937 cell apoptosis. Biomed. Biophys. Res. Com., 246, 484-488.
33. Sherr, C.J. (1993) Mammalian G1 cyclins. Cell, 73, 1059-1065.
34. Weinberg, R.A. (1995) The retinoblastoma protein and cell cycle control. Cell, 81, 323-330.
35. Morgan, D.O. (1995) Principles of CDK regulation. Nature, 274, 131-134.
36. Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K. and Elledge, S.J. (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75, 805-816.
37. Toyoshima, H. and Hunter, T. (1994) p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell, 78, 67-74.
38. Levine, A.J. (1997) p53, the cellular gatekeeper for growth and division. Cell, 88, 323-31.
39. Sakashita, A., Hattori, T., Miller, C.W., Suzushima, H., Asou, N., Takatsuki, K. and Koeffler, H.P. (1992) Mutations of the p53 gene in adult T-cell leukemia. Blood, 79, 477-480.
40. Yamato, K., Oka, T., Hiroi, M., Iwahara, Y., Sugito, S., Tsuchida, N. and Miyoshi, I. (1993) Aberrant expression of the p53 tumor suppressor gene in adult T-cell leukemia and HTLV-I-infected cells. Jpn. J. Cancer. Res., 84, 4-8.
41. Rowan, S., Ludwig, R.L., Haupt, Y., Bates, S., Lu, X., Oren, M. and Vousden, K.H. (1996) Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant. EMBO J., 15, 827-38.
42. Hatta, Y., Hirama, T., Miller, C.W., Yaniada, Y., Tomonaga, M. and Koeffler H.P. (1995) Homozyguus deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia. Blood, 85, 2699-2704.
43. Morosetti, R., Kawamata, N., Gombart, A.F., Miller, C.W., Hatta, Y., Hirama, T., Said, J.W., Tomonaga, M. and Koeffler, H.P. (1995) Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. Blood, 86, 1924-1930.
44. Shiohara, M., el-Deiry, W.S., Wada, M., Nakamaki, T., Takeuchi, S., Yang, R., Chen, D.L., Vogelstein, B. and Koeffler H.P. (1994) Absence of WAF1 mutations in a variety of human malignancies. Blood, 84, 3781-3784.
45. Hatta, Y., Yamada, Y., Tomonaga, M. and Koeffler, H.P. (1997) Extensive analysis of the retinoblastoma gene in adult T cell leukemia/lymphoma (ATL). Leukemia, 11, 984-989.
46. U-Taniguchi, Y., Furuke, K., Masutani, H., Nakamura, H. and Yodoi, J. (1995) Cell cycle inhibition of HTLV-I transformed T cell lines by retinoic acid: the possible therapeutic use of thioredoxin reductase inhibitors. Oncol. Res., 7, 183-189.
47. Huang, S.Y., Chang, C.S., Tang, J.L., Tien, H.F., Kuo, T.L., Huang, S.F., Yao, Y.T., Chou, W.C., Chung, C.Y., Wang, C.H., Shen, M.C. and Chen, Y.C. (1998) Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemia. Br. J. Haematol., 103, 1092-1095.